riluzole has been researched along with Dysarthria, Pseudobulbar in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scott, K | 1 |
Shannon, R | 1 |
Roche-Green, A | 1 |
Searcy, R | 1 |
Woolyhand, G | 1 |
Meeks, G | 1 |
Schuh, M | 1 |
Kraft, P | 1 |
Beck, M | 1 |
Grimm, A | 1 |
Wessig, C | 1 |
Reiners, K | 1 |
Toyka, KV | 1 |
2 other studies available for riluzole and Dysarthria, Pseudobulbar
Article | Year |
---|---|
Pharmacologic Management Strategies in ALS #301.
Topics: Amyotrophic Lateral Sclerosis; Depression; Dyspnea; Guidelines as Topic; Humans; Muscle Spasticity; | 2016 |
[Amyotrophic lateral sclerosis: management of bulbar symptoms].
Topics: Affective Symptoms; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Combined Modality Therapy; | 2010 |